congresses-banner

The content contained is subject

PublicationView

Oral
T-DXd
ESMO 2023 | October 20-24, 2023
Colorectal Cancer
Efficacy and safety of trastuzumab deruxtecan in patients with solid tumors harboring specific activating HER2 mutations: Primary results from the international phase 2 DESTINY-PanTumor01 study
Bob T. Li
Poster
Other/Multi
AACR 2024 | April 5-10, 2024
Colorectal Cancer
Targeted proteomics and next-generation sequencing (NGS) for biomarker discovery in metastatic colorectal cancer (mCRC)
William J. Kelly

footer